I think we have all stumbled on a golden opportunity for POH and...

I think we have all stumbled on a golden opportunity for POH and a TPM insulin patch. The timing is perfect for Fred Banti to have a cup of coffee with the execs at Sanofi even if only to put POH on Sanofi's radar.

The article illustrates the problems big pharma face when trying to market insulin and insulin delivery devices at the same time to the people that count, the Doctors.

The extract of the article which I am referring to is set out as follows:-

One industry executive recently highlighted the difficulty of generating sales synergy by marketing insulin and equipment together. It is hard enough to deliver a focused marketing message on a single product in the small amount of face-time salespeople get with doctors. Adding a second product of a totally different kind adds another layer of complexity.

A TPM insulin patch marketed under the name 'Insulpatch' kills two birds with the one stone when pitching the product to Doctors in the short amount of time sales reps have with them. Its simply brilliant.

The article also illustrates the value and importance of having a future brand and marketing program for POH pipeline drugs in that notwitstanding the science is right you still have to get out and sell those products.